Genentech Shows Off Positive Results From Phase III HEMLIBRA, TECENTRIQ Studies Post author:Sam Post published:November 19, 2017 Post category:BioPharma Data will be submitted to health authorities globally, including the FDA and EMA. Source: BioSpace You Might Also Like Germany's Evotec AG Plans to Hire Scientists and Execs at New U.S. HQ May 29, 2017 31-Year-Old Biotech Guru Brings in Another $55 Million for Axovant February 2, 2017 Syneron Medical Announces Availability Of Its Annual Report On Form 20-F Through Its Website March 23, 2017
Syneron Medical Announces Availability Of Its Annual Report On Form 20-F Through Its Website March 23, 2017
